JSB_LOGO
  • Home
  • About Us
  • Categories
  • Blog
  • News
  • Entertainment
  • Sports
  • Contact Us
Login Register 0
  • Home
  • News
  • Bharat Biotech Dispatches iNCOVACC to Hospitals, the Novel Intranasal Vaccine for COVID
Bharat Biotech Dispatches iNCOVACC to Hospitals, the Novel Intranasal Vaccine for COVID

Bharat Biotech Dispatches iNCOVACC to Hospitals, the Novel Intranasal Vaccine for COVID

The world’s first intranasal heterologous booster dose – iNCOVACC by Bharat Biotech is a two-dose schedule COVID vaccine dispatched to hospitals.
Written by: Arjita Gupta
Edited by: Krutarth Ghosalkar
Last Updated: February 06, 2023

Bharat Biotech had started dispatching iNCOVACC COVID vaccine, which is basically a nasal drop-based booster dose, the world’s first heterologous booster dose. Executive Chairman Dr. Krishna Ella said on 5 February that the distribution of the vaccine to hospitals began two days back and that India as evidenced by this vaccination can innovate for the nation and the rest of the world. He discussed vaccine delivery under the bilateral agreement. The agreement has taken place between UW-Madison Global Health Institute and Ella Foundation.

UW-Madison One Health Center is the sole establishment yet in India first of its kind for the improvement of global health education, medicines, and vaccines. The iNCOVACC COVID vaccination will help to reduce the cost of storage and disposal of biomedical waste. It will also cut the cost of production and distribution as there is no need for needles, syringes, bandages, and alcohol wipes.

The nasal vaccine is new to India, and Mansukh Mandaviya the Union Health Minister, had hinted in December about India’s technical expert committee on immunization was going to recommend the nasal vaccine against Covid to the nation soon. Initially, the vaccine will follow a two-dose schedule along with a heterologous booster dose. It has been approved as an intranasal vaccine for COVID for the first time given as nasal drops.

It was initially on Republic Day 2023 that Mansukh Mandaviya and Union Minister of Science and Technology, Jitendra Singh launched iNCOVACC. Dr. Krishna Ella said on 26 January that the rollout of iNCOVACC has helped India in its goal of establishing a novel platform for vaccine delivery. The vaccine in question is the Adenovirus vaccine whose Phase I, II, and III clinical trials have yielded positive results. It is a pre-fusion stabilized spike protein and a recombinant replication-deficient vaccine.

The vaccine cost is Rs. 325 per dose for large-scale purchases by the State and Central governments. The nasal drops are easy to administer and painless. It stays stable when stored at 2 to 8°C. Dr. Krishna Ella also expressed that India is well prepared for future infectious diseases and variants of the COVID-19 virus and we commit to developing novel vaccine technologies and innovating the same to combat infectious diseases for the good of public health globally.

Recent Post

...
Maruti Suzuki Fronx, MG Comet, Lamborghini Urus S And Other Cars Will Be Launched in April 2023
March 25, 2023
...
Short-Term Capital Gains to Apply on Mutual Funds from 1 April 2023, Know the Details
March 24, 2023
...
Firefly the AI-based Model by Adobe Can Perform Hi-tech Functions
March 23, 2023
...
Microsoft to Develop Mobile Gaming App Store for Smartphones by Early 2024
March 21, 2023
...
Japan PM Fumio Kishida Visits India on 20 March for Two Days to Discuss Bilateral Ties
March 20, 2023
About Us
A Closer View Of The Market

As our tagline suggests, JSB Market Research is a company that offers comprehensive and insightful market research reports helping you to get a closer view of the market.

Our research team has in-house specialists who track the latest News and Entertainment updates occurring in India and abroad and informs the audience with easy-to-understand news pieces. The content strategist and digital marketing department work in tandem to create palpable video materials and actively share them across our official social media channels. We also intensively check out the market scenarios to bring ahead scrutinized blog posts completed with facts and opinions. With ingrained expertise, we are destined to constantly learn, innovate, and share knowledge with everyone.


Company Links
  • Terms & Conditions
  • Disclaimers
  • How To Order
  • Policies
  • Blog
  • News
  • Categories

Follow Us
facebook twitter youtube
instagram linkedin pinterest
Google News
Follow Us

Address
NMS Titanium, Office No. - 807, 8th floor, Plot no .74,Sector 15, Navi Mumbai – 400614, MH- INDIA
contact@jsbmarketresearch.com
+ 91 7710006748
Copyright © JSB Market Research Pvt Ltd 2013 - 2023 All Rights Reserved.
  • Pharmaceuticals
  • Consumer Goods
  • Energy and Utilities
  • Finance and Banking
  • Food and Beverages
  • Defense
  • Healthcare and Medical
  • Technology
  • Leisure
  • Logistics
  • Advertising and Media
  • Paper and Packaging
  • Publishing and Printing
  • Retail
  • Security
  • Telecommunications
  • Textiles and Clothing
  • Travel and Tourism
  • Construction
  • Chemicals
  • Business Services
  • Automotive and Parts
  • Agriculture
  • Materials
  • Aerospace
  • Personal Care
  • Education
  • Company Profile
  • Electronics
  • SWOT Analysis
  • Industrial